Você está aqui > Página Principal > SPP > Secções e Sociedades > Neonatologia > Recomendações > Anticorpo Anti-VSR > Bibliografia
Bibliografia
- Provisional Pan-European Guidelines
- UK Guidance For The Use of Synagis
- Prevention of RSV infection in Spain - Spanish Consensus Committee
- Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. Pediatric Annals 1999; 28: 507-14
- Coelho M - Proposta de utilização do anticorpo monoclonal anti-VSR - Consulta de Pneumologia Infantil, Hospital de Dona Estefânia, Comunicação oral.
- Deshpande S. RSV prevention. Arch Dis Child 2000; 82:88-90
- Fox JL Letters to the Editor. Pediatrics 1999; 104: 994
- Joffe S, Ray T, Escobar GJ, Black SB, Lieu TA. Cost-effectiveness of respiratory virus prophylaxis among preterm infants. Pediatrics 1999; 104: 419-27
- Malley R DeVincenzo J, Ramilo O and al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998; 178: 1555-61
- Moler FW. RSV Immune Globulin Prophylaxis: is an ounce of prevention worth a pound of cure? Pediatrics 1999;
- Moler FW, Brown RW, Faix RG, Gilsdorf JR. Comments on Palivizumab (Synagis). Pediatrics 1999;
- Nadal D, Berger C, Aebi C, Kind C. Prophylaxis for respiratory syncytial virus bronchiolitis. Lancet 1999; 354: 1997
- Piedimonte G, King KA, Holmgren NL, Bertrand PJ, Rodriguez MM, Hirsch RL. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatric Research 2000;47: 351-6
- Prober CG, Sullender WM. Advances in prevention of respiratory syncytial virus infections. J Pediatr 1999; 135: 546-58
- Robinson RF, Nahata MC. Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection. Am J Health-Syst Pharm 2000; 57: 259-64
- Russel AB. Palivizumab: an overview. Hospital Medicine 1999; 60: 873-7
- Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks´ gestation or earlier. Arch Pediatr Adolesc Med 2000; 154: 55-61
- Simoes EA. Respiratory syncytial virus infection. Lancet 1999; 354: 847-52
- Suresh G. Impact-RSV study group report. Letters to the Editor. Pediatrics 1999; 104: 993
- Moler FW, Brown RW, Faix RG, Gilsdorf JR. Comments on Palivizumab (Synagis). Pediatrics 1999; 103 ;495-7
[